Research ArticleArticle
Mechanism for Covalent Binding of MLN3126, an Oral Chemokine C-C Motif Receptor 9 Antagonist, to Serum Albumins
Naohiro Narita, Akio Morohashi, Kimio Tohyama, Toshiyuki Takeuchi, Yoshihiko Tagawa, Takahiro Kondo and Satoru Asahi
Drug Metabolism and Disposition March 2018, 46 (3) 204-213; DOI: https://doi.org/10.1124/dmd.117.078782
Naohiro Narita
Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan (N.N., A.M., K.T., T.T., Y.T., S.A.); and Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, Osaka, Japan (T.K.)
Akio Morohashi
Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan (N.N., A.M., K.T., T.T., Y.T., S.A.); and Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, Osaka, Japan (T.K.)
Kimio Tohyama
Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan (N.N., A.M., K.T., T.T., Y.T., S.A.); and Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, Osaka, Japan (T.K.)
Toshiyuki Takeuchi
Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan (N.N., A.M., K.T., T.T., Y.T., S.A.); and Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, Osaka, Japan (T.K.)
Yoshihiko Tagawa
Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan (N.N., A.M., K.T., T.T., Y.T., S.A.); and Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, Osaka, Japan (T.K.)
Takahiro Kondo
Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan (N.N., A.M., K.T., T.T., Y.T., S.A.); and Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, Osaka, Japan (T.K.)
Satoru Asahi
Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan (N.N., A.M., K.T., T.T., Y.T., S.A.); and Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, Osaka, Japan (T.K.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
MLN3126 Covalent Binding to Serum Albumins
Naohiro Narita, Akio Morohashi, Kimio Tohyama, Toshiyuki Takeuchi, Yoshihiko Tagawa, Takahiro Kondo and Satoru Asahi
Drug Metabolism and Disposition March 1, 2018, 46 (3) 204-213; DOI: https://doi.org/10.1124/dmd.117.078782
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement